SCHEMBL5877608

SCHEMBL5877608

COc1ccc(-c2nc3cc(Cl)ccc3c(=O)n2CC2CCCC(CN)C2)cc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.48
ABCC1 P33527 2/20 0.44
CYP3A4 P08684 3/20 0.44
POLB P06746 2/20 0.44
RXFP1 Q9HBX9 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
KCNH2 Q12809 3/20 0.43
HRH3 Q9Y5N1 2/20 0.43
ALOX5 P09917 1/20 0.42
ADORA3 P0DMS8 1/20 0.41
CYP2D6 P10635 2/20 0.40
HTR2C P28335 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
GHSR Q92847 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5878076 0.94 EGFR (0.46) EGFRABCC1CYP3A4POLBRXFP1
SCHEMBL5877561 0.93 CYP2D6 (0.46) EGFRABCC1CYP3A4POLBRXFP1
SCHEMBL5877717 0.93 EGFR (0.44) EGFRABCC1CYP3A4POLBRXFP1
SCHEMBL5877585 0.91 EGFR (0.52) EGFRABCC1CYP3A4RXFP1MEN1
SCHEMBL5878215 0.90 EGFR (0.48) EGFRABCC1POLBRXFP1MEN1
SCHEMBL5877433 0.89 ABCC1 (0.46) EGFRABCC1CYP3A4POLBRXFP1
SCHEMBL5877136 0.88 EGFR (0.61) EGFRABCC1CYP3A4KCNH2ALOX5
SCHEMBL5878123 0.88 EGFR (0.64) EGFRABCC1CYP3A4MEN1KMT2A
SCHEMBL5877840 0.88 EGFR (0.45) EGFRABCC1CYP3A4POLBMEN1
SCHEMBL5877256 0.87 EGFR (0.48) EGFRABCC1CYP3A4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7060706-B1 Quinazolinones 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2006-06-13 US disclosed
EP-1216233-A1 QUINAZOLINONES MERCK PATENT GmbH (DE) 2002-06-26 EP disclosed
WO-2001023364-A1 QUINAZOLINONES MERCK PATENT GMBH (DE) 2001-04-05 WO disclosed